CTC
HOLX

Central Trust Company’s Hologic HOLX Stock Holding History

Central Trust Company’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-777
Closed -$58.7K – 1624
2026
Q1 		$58.7K Hold
777
– – ﹤0.01% 805
2025
Q4 		$57.9K Sell
777
-30
-4% -$2.19K ﹤0.01% 788
2025
Q3 		$54.5K Hold
807
– – ﹤0.01% 800
2025
Q2 		$52.6K Sell
807
-142
-15% -$8.51K ﹤0.01% 796
2025
Q1 		$58.6K Sell
949
-54
-5% -$3.58K ﹤0.01% 757
2024
Q4 		$72.3K Hold
1,003
– – ﹤0.01% 723
2024
Q3 		$81.7K Sell
1,003
-169
-14% -$13.5K ﹤0.01% 683
2024
Q2 		$87K Hold
1,172
– – ﹤0.01% 678
2024
Q1 		$91.4K Buy
1,172
+19
+2% +$1.41K ﹤0.01% 694
2023
Q4 		$82.4K Sell
1,153
-100
-8% -$6.96K ﹤0.01% 703
2023
Q3 		$87K Sell
1,253
-50
-4% -$3.78K ﹤0.01% 677
2023
Q2 		$106K Buy
1,303
+65
+5% +$5.31K ﹤0.01% 659
2023
Q1 		$99.9K Buy
1,238
+300
+32% +$24.2K ﹤0.01% 662
2022
Q4 		$70.2K Hold
938
– – ﹤0.01% 710
2022
Q3 		$61K Hold
938
– – ﹤0.01% 737
2022
Q2 		$65K Hold
938
– – ﹤0.01% 723
2022
Q1 		$72K Hold
938
– – ﹤0.01% 747
2021
Q4 		$72K Hold
938
– – ﹤0.01% 737
2021
Q3 		$69K Sell
938
-125
-12% -$9.37K ﹤0.01% 721
2021
Q2 		$71K Sell
1,063
-3,067
-74% -$205K ﹤0.01% 682
2021
Q1 		$307K Buy
4,130
+2,907
+238% +$221K 0.01% 447
2020
Q4 		$89K Buy
1,223
+235
+24% +$16.6K ﹤0.01% 607
2020
Q3 		$66K Sell
988
-50
-5% -$3.17K ﹤0.01% 616
2020
Q2 		$59K Buy
1,038
+25
+2% +$1.23K ﹤0.01% 608
2020
Q1 		$36K Hold
1,013
– – ﹤0.01% 666
2019
Q4 		$53K Buy
1,013
+310
+44% +$15.4K ﹤0.01% 667
2019
Q3 		$35K Hold
703
– – ﹤0.01% 702
2019
Q2 		$33K Hold
703
– – ﹤0.01% 716
2019
Q1 		$34K Sell
703
-16
-2% -$721 ﹤0.01% 693
2018
Q4 		$30K Hold
719
– – ﹤0.01% 711
2018
Q3 		$29K Hold
719
– – ﹤0.01% 774
2018
Q2 		$29K Hold
719
– – ﹤0.01% 752
2018
Q1 		$27K Hold
719
– – ﹤0.01% 781
2017
Q4 		$31K Hold
719
– – ﹤0.01% 784
2017
Q3 		$27K Sell
719
-3,964
-85% -$160K ﹤0.01% 790
2017
Q2 		$212K Hold
4,683
– – 0.01% 437
2017
Q1 		$199K Sell
4,683
-329
-7% -$13.4K 0.01% 454
2016
Q4 		$201K Buy
5,012
+4,210
+525% +$162K 0.01% 453
2016
Q3 		$31K Buy
802
+104
+15% +$3.93K ﹤0.01% 780
2016
Q2 		$24K Buy
698
+298
+75% +$10.3K ﹤0.01% 827
2016
Q1 		$14K Hold
400
– – ﹤0.01% 903
2015
Q4 		$15K Hold
400
– – ﹤0.01% 907
2015
Q3 		$16K Sell
400
-68
-15% -$2.7K ﹤0.01% 887
2015
Q2 		$18K Hold
468
– – ﹤0.01% 873
2015
Q1 		$15K Hold
468
– – ﹤0.01% 909
2014
Q4 		$13K Hold
468
– – ﹤0.01% 927
2014
Q3 		$11K Hold
468
– – ﹤0.01% 968
2014
Q2 		$12K Hold
468
– – ﹤0.01% 933
2014
Q1 		$10K Hold
468
– – ﹤0.01% 957
2013
Q4 		$10K Hold
468
– – ﹤0.01% 947
2013
Q3 		$10K Hold
468
– – ﹤0.01% 952
2013
Q2 		$9K Buy
+468
New +$9.78K ﹤0.01% 925

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Central Trust Company's HOLX Position: Q2 2026 in Review

Central Trust Company sold out of Hologic (HOLX) in Q2 2026, closing a stake of 777 shares — an estimated $58.7K sold.

Central Trust Company first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $307K in Q1 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Central Trust Company reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Central Trust Company sold 777 Hologic shares in Q2 2026, an estimated $58.7K.
  • Central Trust Company first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • Central Trust Company's Hologic position peaked at $307K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.